Search Results - "Wolzt, M"

Refine Results
  1. 1

    Effects of P2Y12 receptor inhibition with or without aspirin on hemostatic system activation: a randomized trial in healthy subjects by Traby, L., Kollars, M., Kaider, A., Eichinger, S., Wolzt, M., Kyrle, P. A.

    Published in Journal of thrombosis and haemostasis (01-02-2016)
    “…Essentials In acute coronary syndromes, dual antiplatelet therapy inhibits platelets but confers a bleeding risk. Healthy male volunteers received clopidogrel…”
    Get full text
    Journal Article
  2. 2

    The release of the adipocytokine visfatin is regulated by glucose and insulin by HAIDER, D. G, SCHALLER, G, KAPIOTIS, S, MAIER, C, LUGER, A, WOLZT, M

    Published in Diabetologia (01-08-2006)
    “…The novel insulin-mimetic adipocytokine visfatin has been linked to the metabolic syndrome, but its regulation has not been characterised to date. Since…”
    Get full text
    Journal Article
  3. 3

    Effects of clopidogrel with or without aspirin on the generation of extracellular vesicles in the microcirculation and in venous blood: A randomized placebo controlled trial by Traby, L., Kaider, A., Kollars, M., Eichinger, S., Wolzt, M., Kyrle, P.A.

    Published in Thrombosis research (01-07-2018)
    “…Dual-antiplatelet therapy (DAPT) is a standard strategy in acute coronary heart disease; however, it confers a considerable bleeding risk. Single-antiplatelet…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Hypertensive emergencies are associated with elevated markers of inflammation, coagulation, platelet activation and fibrinolysis by Derhaschnig, U, Testori, C, Riedmueller, E, Aschauer, S, Wolzt, M, Jilma, B

    Published in Journal of human hypertension (01-06-2013)
    “…Data from in vitro and animal experiments suggest that progressive endothelial damage with subsequent activation of coagulation and inflammation have a key…”
    Get full text
    Journal Article
  6. 6

    Feasibility of a ‘reversed’ isolated forearm technique by regional antagonization of rocuronium-induced neuromuscular block: a pilot study by Hamp, T., Mairweck, M., Schiefer, J., Krammel, M., Pablik, E., Wolzt, M., Plöchl, W.

    Published in British journal of anaesthesia : BJA (01-06-2016)
    “…Abstract Background The isolated forearm technique is used to monitor intraoperative awareness. However, this technique cannot be applied to patients who must…”
    Get full text
    Journal Article
  7. 7

    Haem arginate infusion stimulates haem oxygenase‐1 expression in healthy subjects by Doberer, D, Haschemi, A, Andreas, M, Zapf, T‐C, Clive, B, Jeitler, M, Heinzl, H, Wagner, O, Wolzt, M, Bilban, M.

    Published in British journal of pharmacology (01-12-2010)
    “…BACKGROUND AND PURPOSE Haem oxygenase 1 (HO‐1) is an inducible protein that plays a major protective role in conditions such as ischaemia‐reperfusion injury…”
    Get full text
    Journal Article
  8. 8

    Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity by Tobler, K, Freudenthaler, A, Baumgartner-Parzer, S.M, Wolzt, M, Ludvik, B, Nansalmaa, E, Nowotny, P.J, Seidinger, D, Steiner, S, Luger, A, Artwohl, M

    Published in International Journal of Obesity (01-04-2010)
    “…Objective: Circulating endothelial progenitor cells (EPCs), responsible for neoangiogenesis and vascular repair, negatively correlate with vascular dysfunction…”
    Get full text
    Journal Article
  9. 9

    Association of nutritional risk index with metabolic biomarkers, appetite-regulatory hormones and inflammatory biomarkers and outcome in patients with chronic heart failure by Gouya, G, Voithofer, P, Neuhold, S, Storka, A, Vila, G, Pacher, R, Wolzt, M, Hülsmann, M

    “…We aimed to evaluate the association of the nutritional status by using the nutritional risk index (NRI) with metabolic and inflammatory biomarkers, and…”
    Get more information
    Journal Article
  10. 10

    Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial by Heinisch, B. B., Francesconi, M., Mittermayer, F., Schaller, G., Gouya, G., Wolzt, M., Pleiner, J.

    Published in European journal of clinical investigation (01-02-2010)
    “…Eur J Clin Invest 2010; 40 (2): 148–154 Objective  The aim of this study was to investigate the effect of alpha‐lipoic acid (ALA) treatment on…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Impaired insulin stimulation of muscular ATP production in patients with type 1 diabetes by Kacerovsky, M., Brehm, A., Chmelik, M., Schmid, A. I., Szendroedi, J., Kacerovsky‐Bielesz, G., Nowotny, P., Lettner, A., Wolzt, M., Jones, J. G., Roden, M.

    Published in Journal of internal medicine (01-02-2011)
    “…  Kacerovsky M, Brehm A, Chmelik M, Schmid AI, Szendroedi J, Kacerovsky‐Bielesz G, Nowotny P, Lettner A, Wolzt M, Jones JG, Roden M (Karl‐Landsteiner…”
    Get full text
    Journal Article
  14. 14

    Research ethics committees in Europe: trials and tribulations by Druml, Christiane, Wolzt, M., Pleiner, J., Singer, E. A.

    Published in Intensive care medicine (01-09-2009)
    “…Introduction Ethics committees have been an integral part of clinical research since 1975, when they were introduced through the amendment of the Declaration…”
    Get full text
    Journal Article
  15. 15

    Antithrombotic triple therapy and coagulation activation at the site of thrombus formation: a randomized trial in healthy subjects by Weisshaar, S., Litschauer, B., Gouya, G., Mayer, P., Smerda, L., Kapiotis, S., Kyrle, P. A., Eichinger, S., Wolzt, M.

    Published in Journal of thrombosis and haemostasis (01-11-2014)
    “…Summary Background Patients with acute coronary syndrome and concomitant atrial fibrillation may require antithrombotic triple therapy but clinical evidence of…”
    Get full text
    Journal Article
  16. 16

    Effect of systemic high dose vitamin C therapy on forearm blood flow reactivity during endotoxemia in healthy human subjects by Aschauer, S, Gouya, G, Klickovic, U, Storka, A, Weisshaar, S, Vollbracht, C, Krick, B, Weiss, G, Wolzt, M

    Published in Vascular pharmacology (01-04-2014)
    “…Abstract Objective Acute inflammation induced by administration of Escherichia coli lipopolysaccharide endotoxin (LPS) reduces plasma concentrations of vitamin…”
    Get full text
    Journal Article
  17. 17

    Implantable loop recorder in unexplained syncope: classification, mechanism, transient loss of consciousness and role of major depressive disorder in patients with and without structural heart disease by Pezawas, T, Stix, G, Kastner, J, Schneider, B, Wolzt, M, Schmidinger, H

    Published in Heart (British Cardiac Society) (01-04-2008)
    “…To stratify mechanisms and predictors of unexplained syncope documented by an implantable loop recorder (ILR) in patients with and without structural heart…”
    Get more information
    Journal Article
  18. 18

    Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux by Wolzt, M, Samama, M M, Kapiotis, S, Ogata, K, Mendell, J, Kunitada, S

    Published in Thrombosis and haemostasis (01-06-2011)
    “…Edoxaban, an oral direct factor Xa (FXa) inhibitor, is in phase III clinical development for stroke prevention in atrial fibrillation and treatment of venous…”
    Get more information
    Journal Article
  19. 19

    C‐reactive protein is expressed and secreted by peripheral blood mononuclear cells by Haider, D. G., Leuchten, N., Schaller, G., Gouya, G., Kolodjaschna, J., Schmetterer, L., Kapiotis, S., Wolzt, M.

    Published in Clinical and experimental immunology (01-12-2006)
    “…Summary C‐reactive protein (CRP) protects against bacterial pathogens and is a predictor of cardiovascular events. CRP is produced by vascular and…”
    Get full text
    Journal Article
  20. 20

    Angiotensin inhibition stimulates PPARγ and the release of visfatin by Storka, A., Vojtassakova, E., Mueller, M., Kapiotis, S., Haider, D. G., Jungbauer, A., Wolzt, M.

    Published in European journal of clinical investigation (01-11-2008)
    “…ABSTRACT Background  Angiotensin converting enzyme inhibitors (ACE‐I) and angiotensin receptor blockers (ARB) exhibit beneficial antidiabetic effects in…”
    Get full text
    Journal Article